Outpace Bio

📍 Seattle, United States🗓 Founded 2020👥 60 employees💰 Last funded Aug 2021
Biotechnology Research🌐 outpacebio.com
Website LinkedIn
Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that overcome the barriers to efficacy and safety by programming cells to make the right decisions inside patients. Outpace’s suite of technologies drive persistent activity of the cell therapy (OutLast™), recruit a productive immune response in the tumor microenvironment (OutSmart™), and achieve the potency (OutSpacers™), specificity (Co-LOCKR™), and safety (EGFRopt™) necessary to unlock diverse cancer indications. Outpace’s internal and partnered pipeline approach is optimized for rapid clinical validation of its technologies across diverse cell types and manufacturing processes. At Outpace Bio, we believe that the highest performing teams include people from a wide variety of backgrounds and experiences who respectfully challenge each other. We are committed to building an open, diverse, and inclusive culture for all employees.
5
Total investors
5
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
5
Frequently asked questions
Who invested in Outpace Bio?
Outpace Bio has 5 investors on record on gritt.io, including 5 early-stage backers.
When did Outpace Bio last raise funding?
The most recent investment in Outpace Bio recorded on gritt.io was in August 2021.
When was Outpace Bio founded?
Outpace Bio was founded in 2020.
What industry is Outpace Bio in?
Outpace Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Outpace Bio based?
Outpace Bio is headquartered in Seattle, United States.